drugset / Trial / NCT06747832
INK Cells As Maintenance Therapy After Chemoradiotherapy for Small Cell Lung Cancer
Phase 0
Enrolling by invitation
10 enrolled
Guangzhou Ruixin Biotechnological Co., LTD
Weifang People's Hospital · collab
NaSingle-groupOpen-labelTreatment
Summary
This is a clinical study on the use of iNK cells for the treatment of small cell lung cancer.
Timeline
- Start
- 2024-12-15
- Primary completion
- 2026-06-14
- Completion
- 2026-12-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | iNK cells | Cell therapy | 1e+09 cells | Intravenous |